In a patient with diarrhea‑predominant irritable bowel syndrome post‑cholecystectomy presenting with post‑prandial urgency and watery stools, what is the function of the TGR5 (GPBAR1) receptor and how should bile‑acid malabsorption be diagnosed and managed?

TGR5 Receptor Function in Post-Cholecystectomy Bile Acid Diarrhea

TGR5 (GPBAR1) is a G-protein coupled bile acid receptor that mediates the prokinetic and secretory effects of bile acids in the colon, and its activation by excess colonic bile acids directly causes the watery diarrhea and urgency seen in post-cholecystectomy bile acid malabsorption. 1, 2

Mechanism of TGR5-Mediated Diarrhea

TGR5 is expressed on three key cell types in the colon:

• Enteric neurons – where activation triggers peristaltic reflexes and accelerates colonic transit 3
• Enterochromaffin cells – where activation stimulates release of serotonin (5-HT) and calcitonin gene-related peptide (CGRP), both of which are prokinetic transmitters that induce peristalsis 3
• Colonic epithelial cells – where activation paradoxically decreases basal secretory tone but the net effect of excess bile acids is increased fluid secretion 4

When bile acids reach the colon in excess (as occurs after cholecystectomy due to continuous bile flow without gallbladder storage), they activate TGR5 receptors, resulting in:

• Stimulation of colonic peristalsis and accelerated transit 3
• Release of serotonin and CGRP from enterochromaffin cells, amplifying the motor response 3
• Increased stool frequency and reduced stool water reabsorption 3

Diagnostic Approach to Bile Acid Malabsorption

In post-cholecystectomy patients with chronic watery diarrhea and post-prandial urgency, bile acid malabsorption should be the primary diagnostic consideration. 5

First-Line Diagnostic Strategy

An empiric trial of bile acid sequestrants is the most practical first-line approach in North America, given limited test availability. 5

• Start cholestyramine 4 grams once or twice daily with meals 5
• Clinical response within 1-2 weeks strongly suggests bile acid malabsorption as the cause 5
• Response rate is approximately 73% in patients with bile acid diarrhea 6

Available Diagnostic Tests (When Empiric Trial Fails or Confirmation Needed)

If available, the following tests can confirm bile acid malabsorption:

• SeHCAT scan (gold standard, not available in US): retention <15% suggests bile acid diarrhea, <10% is definitive 5
• Serum C4 level: ≥52.5 ng/mL suggests bile acid malabsorption (specificity 83%) 5
• Serum FGF19: ≤61.7 pg/mL suggests bile acid malabsorption (specificity 78%) 5
• 48-hour fecal bile acid measurement: elevated levels confirm excessive bile acid loss 5, 1

The greatest value of C4 and FGF19 lies in their negative predictive value – normal levels make bile acid malabsorption unlikely. 5

Management Algorithm

Step 1: Initial Conservative Management

Before pharmacologic intervention, implement dietary modifications:

• Reduce dietary fat intake initially (fat triggers bile secretion and worsens symptoms) 7, 6
• Eliminate lactose if lactose intolerance is suspected 7
• Ensure adequate hydration: 2,200-4,000 mL total fluid intake daily 7

Step 2: First-Line Pharmacologic Treatment

Bile acid sequestrants are first-line therapy:

• Cholestyramine 4 grams with breakfast and dinner, titrate up to 4 grams three times daily as needed 5, 6
• Alternative: Colesevelam 625 mg, 3 tablets twice daily (better tolerability) 5, 6
• Take 1 hour before or 4 hours after other medications to avoid drug interactions 5

If bile acid sequestrants provide partial benefit but diarrhea persists, add loperamide:

• Start with 4 mg, then 2 mg after each unformed stool (maximum 16 mg/day) 5, 7

Step 3: Evaluate for Coexisting Conditions

If response to bile acid sequestrants is inadequate after 2-4 weeks, consider:

• Small intestinal bacterial overgrowth (SIBO) – occurs in ~30% of post-cholecystectomy patients; treat with rifaximin 550 mg three times daily for 14 days 7, 6
• Pancreatic exocrine insufficiency – trial of pancreatic enzyme replacement therapy 7, 6
• Clostridioides difficile infection – urgent stool testing if recent antibiotic exposure or hospitalization 7

Critical Pitfalls to Avoid

Do not label post-cholecystectomy diarrhea as IBS-D without first excluding bile acid malabsorption – this is a treatable organic cause that will not respond to IBS therapies. 7, 6

Do not wait beyond 3 months for spontaneous improvement – most recovery occurs within the first 3 months post-surgery, and active case-finding improves outcomes. 7

Do not use cholestyramine in patients with severe steatorrhea – paradoxically, it can worsen fat malabsorption by further depleting bile acids needed for fat digestion. 6

Do not overlook red-flag symptoms requiring urgent evaluation:

• Nocturnal diarrhea (waking from sleep to defecate) 7, 8
• Stool output >1.5 L in 24 hours 7
• Weight loss or malnutrition 7, 8
• Severe urgency with fecal incontinence 7

When to Refer to Gastroenterology

Refer if any of the following are present:

• Persistent diarrhea beyond 3 months despite bile acid sequestrants and loperamide 7, 8
• Evidence of malnutrition or significant weight loss 7, 8
• Elevated inflammatory markers (CRP, ESR) or fecal calprotectin >100 μg/g 8
• Anemia or other laboratory abnormalities suggesting organic disease 8